Practical Dermatology: Atopic Dermatitis

661

Understanding Disparities in AD
Practical Dermatology: Atopic Dermatitis
Understanding Disparities in AD
- Raj Chovatiya, MD, PhD
  Peer
Eczema Awareness Month
Practical Dermatology: Atopic Dermatitis
Eczema Awareness Month
- Peter A. Lio, MD
  Peer
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
Practical Dermatology: Atopic Dermatitis
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
- Melinda Gooderham, MSc, MD, FRCPC
  Peer
New Drugs Helping AD Catch Up to Psoriasis
Practical Dermatology: Atopic Dermatitis
New Drugs Helping AD Catch Up to Psoriasis
- H.L. Greenberg, MD
  Peer
Addressing the Unique Challenges of AD Patients
Practical Dermatology: Atopic Dermatitis
Addressing the Unique Challenges of AD Patients
- Patrick Burnett, MD, PhD, FAAD
  Peer
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
Practical Dermatology: Atopic Dermatitis
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)